EZH2 and neoplasm: Of note, tumours with both high EZH2 and BMI1 expression have a HR of 0.6 (95% CI = 0.3 to 1.2) compared with tumours that have high EZH2 and low BMI1, suggesting that the favourable effect of BMI1 overexpression is dominant over the adverse effects of EZH2.